Medicare Enrolled

Dr. Paige Yoshisato, M.D.

Family Medicine - Adult · Vallejo, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
155 GLEN COVE MARINA RD E, Vallejo, CA 94591
7075588699
In practice since 2005 (20 years)
NPI: 1770586802 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yoshisato from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yoshisato? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yoshisato

Dr. Paige Yoshisato is a family medicine - adult specialist in Vallejo, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Yoshisato performed 1,055 Medicare services across 699 unique beneficiaries.

Between the years covered by Open Payments, Dr. Yoshisato received a total of $14,381 from 54 pharmaceutical and/or device companies across 785 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine - adult. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yoshisato is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 24% volume in CA $14,381 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,055
Medicare services
Top 24% in CA for family medicine - adult
699
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~53 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
476 $94 $197
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
165 $61 $111
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
110 $148 $198
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
66 $37 $109
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
43 $35 $40
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
41 $147 $935
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
37 $3 $20
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
37 $71 $90
Pneumococcal conjugate vaccine (PCV20)
An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria.
23 $282 $299
Pneumonia vaccine administration
This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider.
23 $35 $40
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
22 $19 $90
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
12 $125 $276
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,381
Total received (2018-2024)
Avg $2,054/year across 7 years
Top 4% in CA for family medicine - adult
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
785
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,381 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,092
2023
$2,007
2022
$1,993
2021
$2,078
2020
$2,358
2019
$1,949
2018
$1,903

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$357
ABBVIE INC.
$346
Novo Nordisk Inc
$285
Boehringer Ingelheim Pharmaceuticals, Inc.
$244
PFIZER INC.
$200
GlaxoSmithKline, LLC.
$184
Almatica Pharma LLC
$79
AstraZeneca Pharmaceuticals LP
$68
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$67
Lundbeck LLC
$37
Merck Sharp & Dohme LLC
$35
VERTEX PHARMACEUTICALS INCORPORATED
$31
Alkermes, Inc.
$29
Exact Sciences Corporation
$27
Bayer Healthcare Pharmaceuticals Inc.
$25
Phathom Pharmaceuticals, Inc.
$24
Kowa Pharmaceuticals America, Inc.
$20
Astellas Pharma US Inc
$18
Amneal Pharmaceuticals LLC
$18
Top 3 companies account for 47.2% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$1,967
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,597
Novo Nordisk Inc
$1,321
PFIZER INC.
$1,279
AstraZeneca Pharmaceuticals LP
$1,167
Lilly USA, LLC
$972
GlaxoSmithKline, LLC.
$795
AbbVie Inc.
$585
Merck Sharp & Dohme Corporation
$470
Biohaven Pharmaceutical Holding Company Ltd.
$421
SANOFI-AVENTIS U.S. LLC
$402
ABBVIE INC.
$362
Biohaven Pharmaceuticals, Inc.
$330
Kowa Pharmaceuticals America, Inc.
$312
Allergan, Inc.
$183
Allergan Inc.
$167
Teva Pharmaceuticals USA, Inc.
$167
Bayer HealthCare Pharmaceuticals Inc.
$139
Collegium Pharmaceutical, Inc.
$126
Corcept Therapeutics
$117
Eisai Inc.
$108
AbbVie, Inc.
$97
Merck Sharp & Dohme LLC
$97
ARBOR PHARMACEUTICALS, INC.
$87
Almatica Pharma LLC
$79
SANOFI PASTEUR INC.
$78
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$74
Avanir Pharmaceuticals, Inc.
$74
ITI, Inc.
$70
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$67
Takeda Pharmaceuticals U.S.A., Inc.
$63
Bayer Healthcare Pharmaceuticals Inc.
$53
Lundbeck LLC
$37
Amgen Inc.
$36
Amneal Pharmaceuticals LLC
$35
Ironwood Pharmaceuticals, Inc
$33
Astellas Pharma US Inc
$33
Azurity Pharmaceuticals, Inc.
$32
Abbott Laboratories
$32
VERTEX PHARMACEUTICALS INCORPORATED
$31
Alkermes, Inc.
$29
Pernix Therapeutics Holdings, Inc.
$28
Exact Sciences Corporation
$27
Phathom Pharmaceuticals, Inc.
$24
Organon LLC
$22
Daiichi Sankyo Inc.
$20
Metuchen Pharmaceuticals
$20
Seqirus USA Inc
$19
IRONWOOD PHARMACEUTICALS, INC
$19
Smith & Nephew, Inc.
$19
Qiagen, LLC
$18
Otsuka America Pharmaceutical, Inc.
$14
Hikma Pharmaceuticals USA
$13
Iroko Pharmaceuticals, LLC
$13
Top 3 companies account for 34.0% of all-time payments
Associated products mentioned in payments ›
ADACEL · AJOVY · ANORO · AREXVY · ARISTADA · AUSTEDO · Aimovig · AirDuo Digihaler · BAQSIMI · BASAGLAR · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYDUREON · BYSTOLIC · CAPLYTA · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · Cologuard Collection Kit · Creon · Dayvigo · EMGALITY · EUCRISA · Edarbi · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · Fluad Quadrivalent · GARDASIL · GARDASIL 9 · Horizant · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LINZESS · LOREEV XR · LYRICA · Linzess · Livalo · MDX QUANTIFERON · MOUNJARO · Mitigare · NEXPLANON · NURTEC ODT · Nuedexta · Ozempic · PAXLOVID · PNEUMOVAX 23 · PRADAXA · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · QULIPTA · REXULTI · ROTATEQ · RYTARY · Rybelsus · SHINGRIX · SILENOR · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · SYMBICORT · SYNAGIS · Santyl · Stendra · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · Trintellix · UBRELVY · Uloric · VIBERZI · VIIBRYD · VIVLODEX · VOQUEZNA · VRAYLAR · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XTAMPZA · ZOHYDRO ER · ZORYVE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for family medicine - adult in CA.

Looking for a family medicine - adult specialist in Vallejo?
Compare family medicine - adults in the Vallejo area by procedure volume, costs, and industry payment transparency.
Browse family medicine - adults nearby

Geographic Context

Family medicine - adults within 10 mi
32
Per 100K population
7.1
County median income
$99,994
Nearest hospital
KAISER FOUNDATION HOSPITAL AND REHAB CENTER
2.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Yoshisato is a clinical cardiology specialist, with above-average Medicare volume (top 24% in CA), with low-engagement industry engagement in the top 4% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Yoshisato experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Yoshisato performed 476 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yoshisato receive payments from pharmaceutical companies?
Yes. Dr. Yoshisato received a total of $14,381 from 54 companies across 785 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yoshisato's costs compare to other family medicine - adults in Vallejo?
Dr. Yoshisato's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yoshisato) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →